TITE-CLRM: Towards efficient time-to-event dose-escalation guidance of multi-cycle cancer therapies

Lukas Andreas Widmer, Sebastian Weber, Yunnan Xu +1

Treatment of cancer has rapidly evolved over time in quite dramatic ways, for example from chemotherapies, targeted therapies to immunotherapies and chimeric antigen receptor T-cel…